A Part of the University of Maryland Medical Center

Connect with UMGCC
Facebook Twitter YouTube Blog iPhone
Email PageEmail page Print PagePrint page

FOR IMMEDIATE RELEASE: Aug. 9, 2004
Contact: Karen E. Warmkessel, kwarmkessel@umm.edu 410-328-8919
Ellen Beth Levitt eblevitt@umm.edu 410-328-8919

NADER NABIL HANNA, M.D., NAMED HEAD OF SURGICAL ONCOLOGY AT THE UNIVERSITY OF MARYLAND MEDICAL CENTER

Specializing in treating GI cancers, he conducts cutting-edge gene therapy research

Nader Hanna, M.D.

Nader Hanna, M.D., F.A.C.S., F.I.C.S. a surgeon who specializes in treating gastrointestinal (GI) cancers and soft tissue sarcoma, will become head of Surgical Oncology at the University of Maryland Medical Center, effective Aug. 20, 2004. Dr. Hanna will also join the faculty of the University of Maryland School of Medicine.

He comes to Baltimore from the University of Kentucky, where he was an associate professor of surgery and served as director of gastrointestinal clinical research at the Lucille Markey Cancer Center. He is board-certified in general surgery and surgical oncology.

“Dr. Hanna is a very talented surgeon, and we are delighted that he will head our surgical oncology section,” says Stephen T. Bartlett, M.D., the acting chief of surgery at the University of Maryland Medical Center and professor of surgery and medicine and acting chairman of the Department of Surgery at the University of Maryland School of Medicine.

“The University of Maryland Greenebaum Cancer Center is known for its multidisciplinary approach to cancer care, and Dr. Hanna’s skill as a surgeon and expertise in GI oncology make him an important addition to our staff,” says Kevin J. Cullen, M.D., director of the University of Maryland Greenebaum Cancer Center and a professor of medicine at the University of Maryland School of Medicine. “I expect that he will make significant research contributions as well.”

For More Information

Read a Q&A with Dr. Hanna, in which he discusses his goals at UM Greenebaum Cancer Center, his experience with gene therapy, new drug development, future advances in cancer treatment.

Dr. Hanna, who specializes in performing complicated GI cancer surgeries, says that he was drawn to the University of Maryland Greenebaum Cancer Center because of its reputation for excellent, innovative care and its recent recruitment of Dr. Cullen as the new director. Under its new leadership, the cancer center is planning to double the size of its clinical services and research program.

“This is a tremendous opportunity for me to work with surgery, medical oncology and radiation oncology to build a comprehensive GI cancer program that not only provides state-of the-art multidisciplinary care to patients but also advances the science,” Dr. Hanna says. “It is also very important to have effective cancer prevention and screening programs.”

He received his medical degree from Ain Shams University in Cairo, Egypt, in 1985, completed his surgical residency at St. Elizabeth’s Medical Center, Tufts University, in Boston, Mass., and went on to complete two fellowships at the University of Chicago. He joined the University of Kentucky Medical Center in 1998.

His research interests include using adenovirus-mediated gene therapy and genetic radiotherapy to treat cancer.

####


This page was last updated on: January 24, 2007.